Last reviewed · How we verify

NCT05641792: CLUE

Continuous Glucose Monitoring for Emergency Laparotomy

Status unknown NA Last updated 2 February 2023
What this trial tests

NA trial testing CGM (Dexcom G6) in Peritonitis in 50 participants. Status unknown.

Timeline
15 March 2023
Primary endpoint
1 December 2024
1 December 2025

Quick facts

Lead sponsorMedical University of Gdansk
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposesupportive care
Enrollment50
Start date15 March 2023
Primary completion1 December 2024
Estimated completion1 December 2025
Sites1 location across Poland

Drugs / interventions tested

Conditions studied

Sponsor

Medical University of Gdansk

Who can join

18 and older, any sex, with Peritonitis or Surgical Site Infection. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

CLUE trial aims to determine the feasibility and predictive value for surgical site infection (SSI) of continuous glucose monitoring (CGM) in emergency laparotomy patients with diffuse peritonitis.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Peritonitis

Currently open trials in the same condition.

Other Medical University of Gdansk trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05641792.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing